CARDIFF ONCOLOGY, INC. Accrued Professional Fees, Current
CARDIFF ONCOLOGY, INC. (CRDF) had Accrued Professional Fees, Current of $29.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes
us-gaap:AccruedProfessionalFeesCurrent · last filed 2022-11-03
- 2022-09-30: Accrued Professional Fees, Current $29.00K.
- 2022-06-30: Accrued Professional Fees, Current $28.00K.
- 2022-03-31: Accrued Professional Fees, Current $53.00K.
- 2021-12-31: Accrued Professional Fees, Current $63.00K.
| Period end | Accrued Professional Fees, Current | Accrued Professional Fees, Current as first filed |
|---|---|---|
| 2022-09-30 | $29.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $28.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $53.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $63.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $38.00K 10-K · filed 2022-02-24 | $38.18K 10-K · filed 2021-02-25 |
| 2019-12-31 | $21.00K 10-K · filed 2021-02-25 | |
| 2018-12-31 | $107.01K 10-K · filed 2020-02-27 | |
| 2017-12-31 | $54.87K 10-K · filed 2019-03-06 | $0.00 10-K · filed 2018-02-26 |
| 2016-12-31 | $421.31K 10-K · filed 2018-02-26 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |